Chemotherapeutic Activity of Pitavastatin in Vincristine Resistant B-Cell Acute Lymphoblastic Leukemia

SIMPLE SUMMARY: Chemoresistance leads to poor prognostic outcomes in leukemic patients. Investigating the effects of pitavastatin in chemo-resistant ALL cells provides support for repurposing this FDA-approved drug to contribute to novel interventions to eradicate residual tumor cells that thrive in...

Descripción completa

Detalles Bibliográficos
Autores principales: Piktel, Debbie, Moore, Javohn C., Nesbit, Sloan, Sprowls, Samuel A., Craig, Michael D., Rellick, Stephanie L., Nair, Rajesh R., Meadows, Ethan, Hollander, John M., Geldenhuys, Werner J., Martin, Karen H., Gibson, Laura F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913300/
https://www.ncbi.nlm.nih.gov/pubmed/36765664
http://dx.doi.org/10.3390/cancers15030707

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913300/
https://www.ncbi.nlm.nih.gov/pubmed/36765664
http://dx.doi.org/10.3390/cancers15030707

Ejemplares similares